Abbott India Ltd.

27,445

-350 (-1.3%)growUp

ABBOTINDIA Share Price
As on May 20, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap58,416 Cr
P/E Ratio41.23
Dividend Yield0.17 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open27,845
High27,950
NSE SymbolABBOTINDIA
Close27,445
Low27,320
BSE Symbol500488
Previous Years High/Low
1 Year High37,000
3 Year High37,000
5 Year High37,000
1 Year Low25,150
3 Year Low20,751
5 Year Low15,514

Technicals


IndicatorsValueSignal
5-DMA27,725Bearish
10-DMA27,400Bullish
20-DMA26,435.5Bullish
50-DMA26,359.6Bullish
100-DMA26,928.4Bullish
200-DMA28,717.38Bearish

Historical Performance


1 Year
-11%
3 Years
31.3%
5 Years
71.3%
10 Years
485.7%

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsNov-2001
Net Sales3,563
Total Expenditure3,059
Other Income205
Operating Profit709
Interest1
Depreciation45
Profit Before Tax663
Consolidated Net Profit497
Adjusted EPS31
Compounded Sales Growth
10 Years:22.9
5 Years:9.4
3 Years:5.5
TTM:1.8
Compounded Profit Growth
10 Years:43.9
5 Years:19
3 Years:12.1
TTM:3.3
Stock Price CAGR
10 Years:19.3
5 Years:11.3
3 Years:9.5
TTM:-12.7
Return on Equity
10 Years:120.1
5 Years:325
3 Years:446.8
last year:665.6

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 41.23, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a moderate 3-year price CAGR of 8.7%, reflecting average market performance.
  • The stock carries a low beta of 0.3, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹19702 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹64091 million, indicating a large and established business.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 873071.4
No. of Shares: 32 (Approx)
Performance:-12.7%
P/L: ₹-126928.6
NIFTY Performance: -4.7%
1 day Top Gainers
SymbolChange%
ENRIN3459.6(9%)
ERIS1458.2(9%)
TATACOMM1775.6(8%)
PCBL292.65(7%)
GVT&D4679.4(7%)
1 Day Top Losers
SymbolChange%
PIIND2901.2(-7%)
MAPMYINDIA911.95(-6%)
ZEEL82.95(-5%)
BASF3623.5(-5%)
MANYAVAR415.05(-4%)
BALRAMCHIN530.75(-4%)
M&MFIN309(-3%)
AFCONS305.4(-3%)

Top Performing Stocks from the same sector


IOL Chemicals And Pharmaceuticals Ltd.

36.4%

119.54

1 Month Performance

Kilitch Drugs (India) Ltd.

35.8%

183.8

1 Month Performance

Novartis India Ltd.

32.9%

1323

1 Month Performance

Sakar Healthcare Ltd.

32.7%

809

1 Month Performance

Orchid Pharma Ltd.

31.2%

715.3

1 Month Performance

Advanced Enzyme Technologies Ltd.

30.1%

388.9

1 Month Performance

Sun Pharma Advanced Research Company Ltd.

27.1%

183.68

1 Month Performance

Dishman Carbogen Amcis Ltd.

26.1%

211.2

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month